| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Mycenax Biotech Inc (TWO: 4726)
4726 Technical Analysis
5
| As on 16th Sep 2025 4726 STOCK Price closed @ 37.15 and we RECOMMEND Strong Sell for LONG-TERM with Stoploss of 47.60 & Strong Sell for SHORT-TERM with Stoploss of 43.62 we also expect STOCK to react on Following IMPORTANT LEVELS. |
4726STOCK Price
| Open | 37.65 | Change | Price | % |
| High | 38.00 | 1 Day | -0.50 | -1.33 |
| Low | 37.00 | 1 Week | -1.95 | -4.99 |
| Close | 37.15 | 1 Month | -1.05 | -2.75 |
| Volume | 184706 | 1 Year | -0.05 | -0.13 |
| 52 Week High 62.20 | 52 Week Low 27.40 | ||||
TWO Taiwan Most Active Stocks
| 3707 | 63.60 | 1.11% |
| 6182 | 31.95 | 7.21% |
| 8088 | 41.70 | 0.48% |
| 5392 | 50.30 | 5.89% |
| 8358 | 214.00 | 1.66% |
| 5483 | 118.50 | 9.22% |
| 1815 | 62.10 | 1.64% |
| 3260 | 132.00 | 2.72% |
| 5351 | 35.75 | 0.00% |
| 5371 | 113.00 | 3.67% |
TWO Taiwan Top Gainers Stocks
TWO Taiwan Top Losers Stocks
| 4726 Daily Charts |
4726 Intraday Charts |
Whats New @ Bazaartrend |
4726 Free Analysis |
|
|
4726 Important Levels Intraday
| RESISTANCE | 39.08 |
| RESISTANCE | 38.46 |
| RESISTANCE | 38.08 |
| RESISTANCE | 37.70 |
| SUPPORT | 36.61 |
| SUPPORT | 36.22 |
| SUPPORT | 35.84 |
| SUPPORT | 35.22 |
4726 Forecast September 2025
| 4th UP Forecast | 54.49 |
| 3rd UP Forecast | 48.93 |
| 2nd UP Forecast | 45.49 |
| 1st UP Forecast | 42.06 |
| 1st DOWN Forecast | 32.25 |
| 2nd DOWN Forecast | 28.81 |
| 3rd DOWN Forecast | 25.37 |
| 4th DOWN Forecast | 19.81 |
4726 Weekly Forecast
| 4th UP Forecast | 43.80 |
| 3rd UP Forecast | 41.67 |
| 2nd UP Forecast | 40.35 |
| 1st UP Forecast | 39.03 |
| 1st DOWN Forecast | 35.27 |
| 2nd DOWN Forecast | 33.95 |
| 3rd DOWN Forecast | 32.63 |
| 4th DOWN Forecast | 30.50 |
4726 Forecast2025
| 4th UP Forecast | 109.99 |
| 3rd UP Forecast | 86.63 |
| 2nd UP Forecast | 72.19 |
| 1st UP Forecast | 57.75 |
| 1st DOWN Forecast | 16.55 |
| 2nd DOWN Forecast | 2.11 |
| 3rd DOWN Forecast | -12.33 |
| 4th DOWN Forecast | -35.69 |
Mycenax Biotech Inc ( TWO Taiwan Symbol : 4726 )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
4726 Business Profile
Mycenax Biotech Inc. develops and manufactures biopharmaceutical products from mammalian cells and microbials in Taiwan, European, and the United States markets. The company develops monoclonal antibodies, bi-specific antibodies, fc-fusion proteins, recombinant proteins, peptides, protein conjugates (non-toxin), antibody-cell conjugates, enzymes, antigen-binding fragments (Fab), single-chain variable fragments (ScFv), plasmids, DNA vaccines, and glycoproteins. It also provides process development and scale-up, GMP manufacturing, and analytical services, as well as manufacturing technologies and in-house services. The company was founded in 2001 and is headquartered in Miaoli, Taiwan. Address: No.50-7, Keyan Road, Miaoli, Taiwan, 35053
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service